Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors
Late EDR-1 m is significantly correlated with LUTtotal and dose per body weight. It can be accurately predicted using [<sup>111</sup>In] pentetreotide SPECT/CT data.
Authors
- Satoshi Takeuchi (ORCID: https://orcid.org/0000-0003-4847-6609)
- Rina Kimura
- Kohsuke Kudo (ORCID: https://orcid.org/0000-0001-5351-9242)
- Yamato Munakata
- Shirô Watanabe (ORCID: https://orcid.org/0000-0002-7930-0975)
- Takahiro Tsuchikawa (ORCID: https://orcid.org/0000-0002-3847-280X)
- Hiroshi Ishii (ORCID: https://orcid.org/0000-0002-2143-5922)
- N. Wakabayashi (ORCID: https://orcid.org/0009-0008-8810-239X)
- Junki Takenaka (ORCID: https://orcid.org/0000-0002-6049-4474)
- Kenji Hirata (ORCID: https://orcid.org/0000-0003-0036-8975)
Institutions
- Hokkaido University (JP)
- Hokkaido University Hospital (JP)
Publication Details
- Journal
- Annals of Nuclear Medicine
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1007/s12149-025-02044-5
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00